Masimo (MASI) Revenue Growth (3y) (2012 - 2026)
Masimo (MASI) Revenue Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | 0.73% |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -10.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -10.61% |
| Jan 3, 2026 | -15.96% |
| Sep 27, 2025 | -12.22% |
| Jun 28, 2025 | -13.11% |
| Mar 29, 2025 | 6.94% |
| Dec 28, 2024 | 3.99% |
| Sep 28, 2024 | 3.75% |
| Jun 29, 2024 | 4.07% |
| Mar 30, 2024 | 4.33% |
| Dec 30, 2023 | -40.24% |
| Sep 30, 2023 | 19.86% |
| Jul 1, 2023 | 14.80% |
| Apr 1, 2023 | 27.97% |
| Dec 31, 2022 | 41.07% |
| Oct 1, 2022 | 33.86% |
| Jul 2, 2022 | 35.02% |
| Apr 2, 2022 | 9.50% |
| Jan 1, 2022 | 13.65% |
| Oct 2, 2021 | 13.44% |
| Jul 3, 2021 | 12.97% |